As of 06 Nov 2026 15:49 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
No product lines could be read from the latest recorded notice for this medicine, so no presentation-level status is shown. The notice itself is listed in the history below.
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 9 earlier protocols on this record have expired: SSP070 (to 13 Sep 2024), SSP069 (to 13 Sep 2024), SSP068 (to 13 Sep 2024), SSP067 (to 13 Sep 2024), SSP066 (to 13 Sep 2024), SSP065 (to 13 Sep 2024), SSP064 (to 13 Sep 2024), SSP063 (to 13 Sep 2024), SSP062 (to 13 Sep 2024). Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Quetiapine
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2024 — a recurring shortage spanning 1.6 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 29 Jan 2026 | National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited | Safety alert | — | NatPSA/2026/002/MHRA |
| 10 Feb 2025 | Medicine Supply Notification: Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets – Updated | Supply notification | — | MSN/2025/006 |
| 06 Jun 2024 | Medicine Supply Notification: Quetiapine 150mg, 200mg, 300mg tablets | Supply notification | Tier 2 | MSN/2024/070 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)8 Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets · issued 14 Feb 2025 · valid until Various dates, please refer to the summary supply table below, as stated · matched by name PDF ↗
- MSAN(2024)43 Quetiapine 150mg, 200mg, 300mg tablets - UPDATE · issued 24 Jul 2024 · valid until late August 2024, as stated · matched by name PDF ↗
- MSAN(2024)35 Quetiapine 150mg, 200mg, 300mg tablets · issued 11 Jun 2024 · valid until late August 2024, as stated · matched by name PDF ↗